Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label follow-up study of levetiracetam in partial-onset epilepsy
2014-004334-26Phase 3
- Sponsor
- UCB
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of levetiracetam in epilepsy and Focal Onset Epilepsy, sponsored by UCB. Primary endpoint: Occurrence of treatment-emergent adverse events during the study period.
02
Drugs
levetiracetam
03
Conditions
epilepsyFocal Onset Epilepsy
Beyond the preview
Go deeper on 2014-004334-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004334-26.